215 related articles for article (PubMed ID: 7038899)
21. Cimetidine pharmacokinetics.
Abate MA; Hyneck ML; Cohen IA; Berardi RR
Clin Pharm; 1982; 1(3):225-33. PubMed ID: 6764387
[No Abstract] [Full Text] [Related]
22. Comparative pharmacokinetics and pharmacodynamics of cardiac glycosides.
Kelman AW; Sumner DJ; Lonsdale M; Lawrence JR; Whiting B
Br J Clin Pharmacol; 1980 Aug; 10(2):135-43. PubMed ID: 7426275
[TBL] [Abstract][Full Text] [Related]
23. Pharmacokinetic review of digitalis glycosides.
Peters U
Eur Heart J; 1982 Dec; 3 Suppl D():65-78. PubMed ID: 6761129
[No Abstract] [Full Text] [Related]
24. [Determination of cardiac glycoside concentration in the serum].
Erdmann E
Internist (Berl); 1975 Apr; 16(4):185-9. PubMed ID: 124710
[No Abstract] [Full Text] [Related]
25. [Cardiac glycosides: indications, selection and dosage].
Kuhlmann J
Med Klin; 1982 Jan; 77(3):18-22. PubMed ID: 7057727
[No Abstract] [Full Text] [Related]
26. [Diuretic interaction with cardiac glycosides in mitral defect patients].
Bakaev VV; Arkhipova GF; Kelin EP
Vrach Delo; 1979 Nov; (11):25-7. PubMed ID: 524810
[No Abstract] [Full Text] [Related]
27. Clinical pharmacokinetics of cardiac glycosides in patients with renal dysfunction.
Aronson JK
Clin Pharmacokinet; 1983; 8(2):155-78. PubMed ID: 6342898
[No Abstract] [Full Text] [Related]
28. [Pharmacokinetic interaction of drugs with cardiac glycosides; which are clinically important?].
Hooymans PM; Merkus FW
Ned Tijdschr Geneeskd; 1986 Mar; 130(9):395-9. PubMed ID: 2870436
[No Abstract] [Full Text] [Related]
29. [Cardiac glycoside therapy].
Born H
Folia Clin Int (Barc); 1969 Nov; 17(11):534-45. PubMed ID: 5803723
[No Abstract] [Full Text] [Related]
30. [Formulas for the simplified calculation of the effective level of glycosides in heart therapy].
Mitzkat HJ; Bronsert U
Int J Clin Pharmacol; 1972 Apr; 6(1):88-91. PubMed ID: 5048675
[No Abstract] [Full Text] [Related]
31. [Poisoning by cardiac glycosides].
Mikhaĭlov IB
Eksp Klin Farmakol; 1992; 55(6):67-70. PubMed ID: 1305885
[No Abstract] [Full Text] [Related]
32. [Clinical evaluation of the effectiveness of treatment with cardiac glycosides].
Mukharliamov NM; Tsibekmakher TD
Kardiologiia; 1975 Jul; 15(7):141-53. PubMed ID: 1206841
[No Abstract] [Full Text] [Related]
33. [Use of phentolamine in the treatment of cardiovascular diseases (literature review)].
Sakharchuk II; Bil'kevich LT; Denisenko GT; Sidorenko ID; Shostka IP
Vrach Delo; 1981 Nov; (11):57-61. PubMed ID: 7043896
[No Abstract] [Full Text] [Related]
34. [Drug interaction with cardiac glycosides (a review of the literature)].
Chekman IS; Viktorov AP; Angelutsa PA; Grinevich AI; Roshchupkina EV
Vrach Delo; 1990 Jul; (7):32-7. PubMed ID: 2238591
[No Abstract] [Full Text] [Related]
35. [Studies on the pharmacokinetics of meproscillarin (author's transl)].
Belz GG; Belz G
Arzneimittelforschung; 1978; 28(3a):535-9. PubMed ID: 580584
[No Abstract] [Full Text] [Related]
36. [Rational prescription of cardiac stimulants].
Rietbrock N; Abshagen U; von Bergmann K; Kewitz H
Dtsch Med J; 1972 Feb; 23(2):100-5. PubMed ID: 5017962
[No Abstract] [Full Text] [Related]
37. [On the pharmacokinetics of peruvoside. I. Comparative clinical and experimental animal studies].
Hundeshagen H; Zeidler U; Fabel H; Garbe A; Nowak H
Arzneimittelforschung; 1968 Dec; 18(12):1592-6. PubMed ID: 5756259
[No Abstract] [Full Text] [Related]
38. [Clinical experiences with a squill preparation (proscillaridin A) in oral administration].
Rosini E; Petacchi R
Minerva Med; 1967 Dec; 58(96):4301-18. PubMed ID: 6083292
[No Abstract] [Full Text] [Related]
39. [Pharmacokinetic differentiation of cardiac glycosides].
Wirth KE
Verh Dtsch Ges Herz Kreislaufforsch; 1982; 48():19-27. PubMed ID: 7187160
[No Abstract] [Full Text] [Related]
40. Proceedings: The influence of cardiac glycosides on membrane currents in mammalian myocardium.
Nawrath H; McDonald TF; Trautwein W
Naunyn Schmiedebergs Arch Pharmacol; 1975; 287 Suppl():R24. PubMed ID: 1143408
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
